Enhancement of sodium borocaptate (BSH) uptake by tumor cells induced by glutathione depletion and its radiobiological effect

Cancer Letters

Volumn 215, Issue 1, 2004, Pages 61-67

  Yoshida, Fumiyo ^a   Matsumura, Akira ^a   Yamamoto, Tetsuya ^a   Kumada, Hiroaki ^b   Nakai, Kei ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JAPAN ATOMIC ENERGY AGENCY   (Japan)

Author keywords

Buthionine sulfoximine; Gamma irradiation; Glutathione; Neutron; Sodium borocaptate

Indexed keywords

BOROCAPTATE; BUTHIONINE SULFOXIMINE; GLUTATHIONE; THIOL DERIVATIVE;

ANIMAL CELL; ARTICLE; BRAIN TUMOR; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG UPTAKE; GAMMA RADIATION; HAMSTER; MOUSE; NEUTRON CAPTURE THERAPY; NEUTRON RADIATION; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL;

ANIMALS; BOROHYDRIDES; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; BUTHIONINE SULFOXIMINE; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; CRICETINAE; DOWN-REGULATION; GAMMA RAYS; GLIOMA; GLUTATHIONE; LUNG; MICE; RADIATION-SENSITIZING AGENTS; RATS; RELATIVE BIOLOGICAL EFFECTIVENESS; SULFHYDRYL COMPOUNDS;

EID: 4544308890     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.06.023     Document Type: Article

References (20)

1. H. Hatanaka, and Y. Nakagawa Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy Int. J. Radiat. Oncol. Biol. Phys. 28 1994 1061 1066
2. 11SH J. Neurosurg. 81 1994 741 744
3. W. Yang, R.F. Barth, J.H. Rotaru, M.L. Moeschberger, D.D. Joel, and M.M. Nawrocky Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption Int. J. Radiat. Oncol. Biol. Phys. 37 1997 663 672
4. J.B. Mitchell, J.E. Biaglow, and A. Russo Role of glutathione and other endogenous thiols in radiation protection Pharmacol. Ther. 39 1988 269 274
5. R. Ryu, Y. Shin, J.W. Choi, W. Min, H. Ryu, C.R. Choi, and H. Ko Depletion of intracellular glutathione mediates zinc-induced cell death in rat primary astrocytes Exp. Brain Res. 143 2002 257 263
6. C.L. Chen, C.W. Chi, and T.Y. Liu Enhanced hydroxychavicol-induced cytotoxic effect in glutathione-depleted HepG2 cells Cancer Lett. 155 2000 29 35
7. - and maintenance of intracellular glutathione levels in pancreatic acinar and islet cell lines Biochim. Biophys. Acta 1414 1998 85 94
8. K. Miura, T. Ishii, Y. Sugita, and S. Bannai Cystine uptake and glutathione level in endothelial cells exposed to oxidative stress Am. J. Physiol. 262 1992 C50 C58
9. P.J. O'Dwyer, T.C. Hamilton, R.C. Young, F.P. LaCreta, N. Carp, and K.D. Tew Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results J. Natl Cancer Inst. 84 1992 264 267
10. R.A. Britten, H.M. Warenius, R. White, and J. Peacock BSO-induced reduction of glutathione levels increases the cellular radiosensitivity of drug-resistant human tumor cells Int. J. Radiat. Oncol. Biol. Phys. 22 1992 769 772
11. H. Ito, K. Okamoto, and K. Kato Enhancement of expression of stress protein by agents that lower the levels of glutathione in cells Biochim. Biophys. Acta 1397 1998 223 230
12. F. Yoshida, A. Matsumura, Y. Shibata, T. Yamamoto, H. Nakauchi, M. Okumura, and T. Nose Cell cycle dependence of boron uptake from two boron compounds used for clinical neutron capture therapy Cancer Lett. 187 2002 135 141
13. J.B. Schulz, J. Lindenau, J. Seyfried, and J. Dichgans Glutathione, oxidative stress and neurodegeneration Eur. J. Biochem. 267 2000 4904 4911
14. K.D. Tew Glutathione-associated enzymes in anticancer drug resistance Cancer Res. 54 1994 4313 4320
15. S. Winter, H. Strik, J. Rieger, J. Beck, R. Meyermann, and M. Weller Glutathione S-transferase and drug sensitivity in malignant glioma J. Neurol. Sci. 179 2000 115 121
16. P. von Bossanyi, S. Diete, K. Dietzmann, M. Warich-Kirches, and E. Kirches Immunohistochemical expression of P-glycoprotein and glutathione S-transferases in cerebral gliomas and response to chemotherapy Acta. Neuropathol. 94 1997 605 611
17. M. Gosland, B. Lum, J. Schimmelpfennig, J. Baker, and M. Doukas Insights into mechanisms of cisplatin resistance and potential for its clinical reversal Pharmacotherapy 16 1996 16 39
18. K. Hamaguchi, A.K. Godwin, M. Yakushiji, P.J. O'Dwyer, R.F. Ozols, and T.C. Hamilton Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines Cancer Res. 53 1993 5225 5232
19. M. Tagashira, N. Nozato, S. Isonishi, A. Okamoto, K. Ochiai, and Y. Ohtake 5-Hydroxy-4-l-norvaline depletes intracellular glutathione: a new modulator of drug resistance Biosci. Biotechnol. Biochem. 63 1999 1953 1958
20. L. Pendyala, P.J. Creaven, G. Schwartz, N.J. Meropol, W. Bolanowska-Higdon, and J. Zdanowicz Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione Clin. Cancer Res. 6 2000 1314 1321